高级搜索
NP方案与FLP 方案联合放疗治疗食管癌疗效对比研究[J]. 肿瘤防治研究, 2005, 32(09): 577-579. DOI: 10.3971/j.issn.1000-8578.2379
引用本文: NP方案与FLP 方案联合放疗治疗食管癌疗效对比研究[J]. 肿瘤防治研究, 2005, 32(09): 577-579. DOI: 10.3971/j.issn.1000-8578.2379
A Randomized Trial of NP Therapy Plus Radiotherapy Versus FLP Therapy Plus Radiotherapy in the Treatment of Esophagus[J]. Cancer Research on Prevention and Treatment, 2005, 32(09): 577-579. DOI: 10.3971/j.issn.1000-8578.2379
Citation: A Randomized Trial of NP Therapy Plus Radiotherapy Versus FLP Therapy Plus Radiotherapy in the Treatment of Esophagus[J]. Cancer Research on Prevention and Treatment, 2005, 32(09): 577-579. DOI: 10.3971/j.issn.1000-8578.2379

NP方案与FLP 方案联合放疗治疗食管癌疗效对比研究

A Randomized Trial of NP Therapy Plus Radiotherapy Versus FLP Therapy Plus Radiotherapy in the Treatment of Esophagus

  • 摘要: 目的 通过对比NP+放疗与FLP+放疗治疗食管癌疗效及毒副作用,寻求食管癌更有效的治疗方法。方法 63例初治的食管癌患者随机分为A、B二组。A组31例NP(NVB+DDP)方案2周期+放疗肿瘤量6500cGy左右;B组32例FLP(5-Fu/CF+DDP)方案2周期+放疗肿瘤量6500cGy左右。结果 A组总有效率83.9%,中位生存时间14.7月,1年生存率76.0%;B组总有效率71.9%,中位生存时间12.3月,1年生存率69.0%;P值均〉0.05;主要毒副作用是骨髓抑制,A组III~IV度白细胞减少占16.1%,B组占6.3%,P〉0.05。结论 NP+放疗治疗食管癌总有效率和1年生存率均高于FLP+放疗,差异虽无显著性,但NP加放疗具有较高的CR率,症状改善明显,毒副作用能耐受。

     

    Abstract: Objective  To compare the response rate and the side effects of the regimen NPR (NVB + DDP+ radiotherapy) with the regimen FLPR ( FLP (5-Fu/ CF + DDP) + radiotherapy) in the treatment of eophagus. Methods  A total of 63 cases with esophagus entered this trial. The patient s were randomly divided into two groups, group A with 31 cases and group B with 32 cases. The patient s in group A received the NPR regimen ( i. e. NP therapy for two cycles and then palliative radiotherapy with about 6500cGy), and the patients in group B received the FLPR regimen ( FLP therapy for two cycles and then palliative radiotherapy with about 6500cGy) . Results  ①The total response rate of the NPR regimen was 83. 9 %, the median survival time (MST) was 14. 7 months, the one-year survival rate ( YSR) was 76. 0 %, but the total response rate of FLPR regimen was 71. 9 %, MST was 12. 3 months, YSR 69. 0 %, and there was no significant difference between these two regimens ( P > 0. 05) ; ②The main side effect of these two regimens was bone marrow depression, and the grade Ⅲ~ Ⅳ leucopenia was 16. 1 % in group A, and 6. 3 % in group B ( P > 0. 05) . Conclusion  The total response rate and the one-year survival rate of the NPR regimen were higher than the FLPR regimen. Although there was no significant difference between these two regimens, the patient s treated with the NPR regimens has higher CR rate compared with the FL PR regimen, and can tolerate the poisonous and side effects.

     

/

返回文章
返回